What should investors do with Cadila Healthcare after Q1 earnings: buy, sell or hold?

Cadila Healthcare share price shed 2 percent in the early trade on August 12, a day after the pharma company reported a 29 percent year-on-year (YoY) jump in net profit at Rs 587 crore for the quarter ended June 30 (Q1FY22) led by strong growth in domestic…

Click here to view the original article.